CytoDyn (CYDY) Non-Current Assets (2011 - 2026)
CytoDyn (CYDY) posted Non-Current Assets of $59000.0 for Q1 2026, down 38.54% on a QoQ basis from $96000.0 in Q4 2025, and down 71.5% year-over-year from $207000.0 in Q1 2025.
CytoDyn (CYDY) Non-Current Assets (2011 - 2026) Analysis & Trends
CytoDyn's Non-Current Assets history runs 16 years deep, the most recent figure standing at $59000.0 for Q1 2026.
- Quarterly Non-Current Assets fell 71.5% year-over-year to $59000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $457000.0 (down 56.68% YoY) and the FY2025 annual result came in at $169000.0, down 47.35% from the prior year.
- Non-Current Assets was $59000.0 for Q1 2026 at CytoDyn, down from $96000.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $18.7 million in Q2 2022 and bottomed at $59000.0 in Q1 2026.
- A 5-year average of $2.5 million and a median of $360000.0 in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets surged 748.76% — and 2023, when it slumped 97.61%.
- CytoDyn's Non-Current Assets stood at $523000.0 in 2022, then decreased by 23.52% to $400000.0 in 2023, then plunged by 39.0% to $244000.0 in 2024, then plunged by 60.66% to $96000.0 in 2025, then slumped by 38.54% to $59000.0 in 2026.
- Business Quant data shows CYDY's Non-Current Assets at $59000.0 in Q1 2026, $96000.0 in Q4 2025, and $133000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - | 59,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 59,000.00 |
| Nov 30, 2025 | 96,000.00 |
| Aug 31, 2025 | 133,000.00 |
| May 31, 2025 | 169,000.00 |
| Feb 28, 2025 | 207,000.00 |
| Nov 30, 2024 | 244,000.00 |
| Aug 31, 2024 | 283,000.00 |
| May 31, 2024 | 321,000.00 |
| Feb 29, 2024 | 360,000.00 |
| Nov 30, 2023 | 400,000.00 |
| Aug 31, 2023 | 443,000.00 |
| May 31, 2023 | 487,000.00 |
| Feb 28, 2023 | 532,000.00 |
| Nov 30, 2022 | 523,000.00 |
| Aug 31, 2022 | 18.54 Mn |
| May 31, 2022 | 18.67 Mn |
| Feb 28, 2022 | 1.73 Mn |
| Nov 30, 2021 | 1.89 Mn |
| Aug 31, 2021 | 2.18 Mn |
| May 31, 2021 | 95.98 Mn |